To be cost-effective, injectable PrEP can only cost about $3000 more than US generic oral PrEP
Far fewer people would get PrEP in the US if generic TDF/FTC is replaced with Descovy (TAF/FTC), cost-effectiveness study finds
Rapid adoption of generic HIV drugs could save NHS £7 billion by 2033
Why has the uptake of lopinavir/ritonavir oral pellets for children been slow?
Glimmers of hope: moving towards better HIV and TB treatment in eastern Europe
Generic PrEP bought online has correct amounts of emtricitabine and tenofovir
Most PrEP users in Berlin obtained it from informal channels
NHS England saved £10 million by switching to generic anti-HIV drugs in 2016
